ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Astragaloside IV mitigates mitochondrial damage and neurological symptoms in rats with cervical spondylotic myelopathy by inhibiting IL-17/TRAF6/NF-κB pathway.

Xin Han et al.PubMed ↗Publisher ↗

No numbers read from the abstract.